Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cardiology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cardiology Other
    The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials - (BMJ)
    FDA Approves Dronedarone for Atrial Fibrillation or Atrial Flutter - (DGNews)
    Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease - (JAMA)
    Novel and conventional biomarkers for prediction of incident cardiovascular events in the community - (JAMA)
    Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study - (BMJ)

    News archive

     Recent webcasts/CME - Cardiology Other
    • State of the Science in Managing the Treatment-Experienced Patient With HIV
    • What's New in Managing Treatment-Experienced Patients With HIV?
    • Applying Data to Practice: Case Vignettes
    • Rheumatoid Arthritis: The Heart of the Matter Assessing Cardiovascular Risk in Patients with Rheumatoid Arthritis
      Supraventricular Tachycardia in Children and Adolescents

      Webcasts/CME archive

       Recent cases - Cardiology Other
        Cardiogenic Shock Caused by Disulfiram
        Congenital Atresia of the Left Main Coronary Artery Associated With Patent Ductus Arteriosus and Aortic Regurgitation
        Pleural Effusion and Pulmonary Hypertension in a Patient With Parkinson Disease Treated With Cabergoline
        A Well-Circumscribed Density Along the Right Heart Border
        A Case of Massive Pulmonary Embolism with ST Elevation in Leads V1-4

        Cases archive
          




        my personal edition > cardiology other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Mediterranean Diet Independently Lowers Cardiovascular Disease Risk: Presented at AHA

        By Charlene Laino

        ORLANDO, FL -- November 10, 2003 -- A Mediterranean diet rich in olive oil and lean on meat lowered the levels of several inflammation and coagulation markers related to cardiovascular disease (CVD), a cross-sectional study shows.

        Demosthenes Panagiotakos, PhD, lecturer in the department of nutrition and dietetics at Harokopio University, Athens, Greece, presented the findings here November 10th at the American Heart Association's Scientific Sessions 2003.

        While studies have suggested that adherence to the Mediterranean diet may reduce the risk of cardiovascular disease by up to 30%, it is not fully understood how the diet exerts its protective effect, according to Dr. Panagiotakos. "Some have suggested it lowers blood pressure; others speculate it reduces cholesterol levels. Still others say it is not the diet itself but other characteristics of people who follow the diet, such as a healthy lifestyle."

        For the new study, the researchers chose to evaluate markers of inflammation and coagulation, applying a multivariate analysis to account for the effects of any confounding factors.

        The study enrolled 2,282 men and women, age 18 to 89 years, without heart disease. The researchers used a special nutritional questionnaire, developed by the National School of Public Health, to track consumption of red meat, chicken, fish, vegetables, legumes, pasta, salads, cereals, diary products, sweets, and fruits. Plasma levels of C-reactive protein, interleukin-6, homocysteine, and fibrinogen were measured after a 12-hour fast.

        Univariate analysis showed that adoption of a Mediterranean diet was associated with a significant reduction in levels of C-reactive protein, fibrinogen, homocysteine, and interluekin-6, Dr. Panagiotakos reported.

        In multivariate analysis that controlled for body mass index, age, gender, education, and physical activity, adoption of the diet was associated with a 0.22 mg/dL drop in C-reactive protein levels, a 0.21 pg/mL drop in interluekin-6, a 12.5 mg/dL decrease in fibrinogen, and a 0.87 mmol/L drop in homocysteine levels, he said.

        The study not only provides a pathophysiological explanation for the growing evidence of a beneficial effect of the Mediterranean diet, but also "clearly shows that the beneficial effect of this diet was independent of any of these other factors," he said in an interview.

        While the cross-sectional design of the study precludes establishment of a causal relationship, Dr. Panagiotakos suggested that patients should be counseled that the benefits "were from the diet as a whole, not from specific items consumed."


        [Study title: The Benefits From the Consumption of Mediterranean Diet on Inflammation Process: The ATTICA Study. Abstract 3348]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send